NCT01593215View on ClinicalTrials.gov

Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Type 2 Diabetes
Interventions
DRUG

Yohimbine

Yohimbine capsule

Trial Locations (1)

20502

Skanes Universitetssjukhus, Malmo

All Listed Sponsors
collaborator

Region Skane

OTHER

collaborator

Lund University

OTHER

lead

Anders Rosengren, MD PhD

OTHER

NCT01593215 - Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant | Biotech Hunter | Biotech Hunter